Deutsche Bank’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-879
| Closed | -$60K | – | 4247 |
|
|
2022
Q1 | $60K | Sell |
879
-421
| -32% | -$28.7K | ﹤0.01% | 3709 |
|
|
2021
Q4 | $158K | Sell |
1,300
-548
| -30% | -$66.6K | ﹤0.01% | 3454 |
|
|
2021
Q3 | $260K | Buy |
1,848
+832
| +82% | +$117K | ﹤0.01% | 3398 |
|
|
2021
Q2 | $280K | Buy |
1,016
+176
| +21% | +$48.5K | ﹤0.01% | 3557 |
|
|
2021
Q1 | $180K | Buy |
840
+24
| +3% | +$5.14K | ﹤0.01% | 3656 |
|
|
2020
Q4 | $198K | Buy |
816
+250
| +44% | +$60.7K | ﹤0.01% | 3418 |
|
|
2020
Q3 | $60K | Buy |
566
+179
| +46% | +$19K | ﹤0.01% | 3728 |
|
|
2020
Q2 | $38K | Buy |
387
+161
| +71% | +$15.8K | ﹤0.01% | 3867 |
|
|
2020
Q1 | $16K | Sell |
226
-132
| -37% | -$9.35K | ﹤0.01% | 3861 |
|
|
2019
Q4 | $28K | Buy |
358
+172
| +92% | +$13.5K | ﹤0.01% | 4049 |
|
|
2019
Q3 | $21K | Sell |
186
-391
| -68% | -$44.1K | ﹤0.01% | 4131 |
|
|
2019
Q2 | $102K | Sell |
577
-340
| -37% | -$60.1K | ﹤0.01% | 4069 |
|
|
2019
Q1 | $145K | Buy |
917
+15
| +2% | +$2.37K | ﹤0.01% | 4051 |
|
|
2018
Q4 | $234K | Buy |
902
+294
| +48% | +$76.3K | ﹤0.01% | 3707 |
|
|
2018
Q3 | $148K | Buy |
608
+94
| +18% | +$22.9K | ﹤0.01% | 4221 |
|
|
2018
Q2 | $121K | Buy |
+514
| New | +$121K | ﹤0.01% | 4311 |
|